Terlipressin [terlipresin]
- Terms
-
Glypresin
Glypressin
N-triglycyl-8-lyzin-vazopresin
Remestyp
triglycyl-lysin-vazopresin
-
Glipressin
Gly-Gly-Gly-8-Lys-vasopressin
Glycylpressin
Glypressin
N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin
Remestyp
Terlypressin
TGLVP
Triglycyl Lysine Vasopressin
Triglycyl-(8-lysine)vasopressin
Triglycylvasopressin
Vasopressin, tri-Gly-8-Lys-
An inactive peptide prodrug that is slowly converted in the body to lypressin. It is used to control bleeding of ESOPHAGEAL VARICES and for the treatment of HEPATORENAL SYNDROME.
- DUI
- D000077585 MeSH Browser
- CUI
- M0058831
- CAS
- N-(N- (N-glycylglycyl)glycyl)-L-lysinevasopressin
- History note
- 2019 (1976)
- Public note
- 2019; TERLIPRESSIN was indexed under LYPRESSIN/analogs & derivatives 1976-2018
Allowable subheadings
- AD
- administration & dosage 2
- AE
- adverse effects 1
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- DE
- drug effects
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 2
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 5
- TO
- toxicity
- UR
- urine
terlivaz Chemical MeSH Browser